Increased expression and cell surface localization of MT1-MMP plays a role in stimulation of MMP-2 activity by leptin in neonatal rat cardiac myofibroblasts (Q46627327)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 March 2008

Language	Label	Description	Also known as
English	Increased expression and cell surface localization of MT1-MMP plays a role in stimulation of MMP-2 activity by leptin in neonatal rat cardiac myofibroblasts	scientific article published on 12 March 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436234

Increased expression and cell surface localization of MT1-MMP plays a role in stimulation of MMP-2 activity by leptin in neonatal rat cardiac myofibroblasts (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436234

author name string

Kristin Schram

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436234

Maggie M C Wong

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436234

Rengasamy Palanivel

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436234

Eun Kyung No

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436234

Ian M C Dixon

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436234

Gary Sweeney

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436234

publication date

12 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436234

Journal of Molecular and Cellular Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436234

44

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436234

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436234

874-881

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436234

Cardiac remodeling in obesity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

The metabolic syndrome and adipocytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Leptin induces elongation of cardiac myocytes and causes eccentric left ventricular dilatation with compensation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Direct effects of leptin on size and extracellular matrix components of human pediatric ventricular myocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Leptin, obesity and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Leptin signalling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Role of selective leptin resistance in diet-induced obesity hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Obesity-related hypertension: is there a role for selective leptin resistance?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Rat heart is a site of leptin production and action

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Leptin resistance and obesity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

The concept of selective leptin resistance: evidence from agouti yellow obese mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Hyperleptinaemia in chronic heart failure. Relationships with insulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United States population

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Cardiac remodeling and failure From molecules to man (Part II).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Matrix metalloproteinases: regulation and dysregulation in the failing heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

ECM remodeling in hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

The cardiac fibroblast: therapeutic target in myocardial remodeling and failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Globular and full-length forms of adiponectin mediate specific changes in glucose and fatty acid uptake and metabolism in cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

(-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

(-)-Epigallocatechin-3-gallate, a polyphenolic compound from green tea, inhibits fibroblast adhesion and migration through multiple mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Leptin and hyperleptinemia - from friend to foe for cardiovascular function

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Ischemia/reperfusion in rat heart induces leptin and leptin receptor gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

A Matrix Metalloproteinase Induction/Activation System Exists in the Human Left Ventricular Myocardium and Is Upregulated in Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

MT1-MMP: a tethered collagenase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Collagen biosynthesis by human skin fibroblasts. II. Isolation and further characterization of type I and type III procollagens synthesized in culture.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Precursors of collagen secreted by cultured human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-beta type II receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [seecomments]

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.005

7 January 2021

Identifiers

10.1016/J.YJMCC.2008.03.005

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436234

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436234

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46627327&oldid=2123047800"